Research Paper Volume 15, Issue 20 pp 11532—11545

Indoxyl sulfate induced frailty in patients with end-stage renal disease by disrupting the PGC-1α–FNDC5 axis

class="figure-viewer-img"

Figure 1. ROC curve for handgrip strength. Irisin: 0.298 (95% CI: 0.139–0.457) and indoxyl sulfate: 0.733 (95% CI: 0.575–0.890).